Amino terminal glycation of gastric inhibitory polypeptide enhances its insulinotropic action on clonal pancreatic B-cells

Biochimica et Biophysica Acta - General Subjects

Volumn 1425, Issue 2, 1998, Pages 319-327

  O'Harte, Finbarr P M ^a   Abdel Wahab, Yasser H A ^a   Conlon, J Michael ^b   Flatt, Peter R ^a  

^a UNIVERSITY OF ULSTER   (United Kingdom)

^b CREIGHTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

BRIN BD11; Gastric inhibitory polypeptide; Glycation; Insulin secretion; Pancreatic B cell

Indexed keywords

GASTRIC INHIBITORY POLYPEPTIDE; GLUCOSE; INSULIN;

AMINO TERMINAL SEQUENCE; ARTICLE; CELL CLONE; CONTROLLED STUDY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HORMONE STRUCTURE; INSULIN RELEASE; MASS SPECTROMETRY; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; PROTEIN GLYCOSYLATION;

AMINO ACIDS; CLONE CELLS; GASTRIC INHIBITORY POLYPEPTIDE; GLYCOSYLATION; HUMANS; INSULIN; ISLETS OF LANGERHANS; MASS SPECTROMETRY;

EID: 0031757194     PISSN: 03044165     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-4165(98)00084-1     Document Type: Article

References (50)

1. J.C. Brown, Enteroinsular axis, in: J.H. Walsh, G.J. Dockray (Eds.), Gut Peptides, Biochemistry and Physiology, Raven Press, New York, 1994, pp. 765-784.
2. A.M.J. Buchan, J.M. Polak, C. Capella, E. Solcia, A.G.E. Pearse, Electronimmunocytochemical evidence for the K cell localization of gastric inhibitory polypeptide (GIP) in man, Histochemistry 546 (1978) 37-44.
3. S. Sykes, L.M. Morgan, J. English, V. Marks, Evidence for preferential stimulation of gastric inhibitory polypeptide secretion in the rat by actively transported carbohydrates and their analogues, J. Endocrinol. 85 (1980) 201-207.
4. P. Kwasowski, P.R. Flatt, C.J. Bailey, V. Marks, Effect of fatty acid chain length and saturation on gastric inhibitory peptide release in obese hyperglycaemic (ob/ob) mice, Biosci. Rep. 5 (1985) 701-705.
5. P.R. Flatt, P. Kwasowski, R.J. Howland, C.J. Bailey, Gastric inhibitory polypeptide and insulin responses to orally administered amino acids in genetically obese hyperglycaemic (ob/ob) mice, J. Nutr. 121 (1991) 1123-1128.
6. S. Cataland, S.E. Crockett, J.C. Brown, E.L. Mazzaferri, Gastric inhibitory polypeptide (GIP) stimulation by oral glucose in man, J. Clin. Endocrinol. Metab. 39 (1974) 223-228.
7. T. Krarup, J.J. Holst, K.L. Larsen, Responses and molecular heterogeneity of IR-GIP after intraduodenal glucose and fat, Am. J. Physiol. 249 (1985) E195-E200.
8. R.A. Pedersen, Gastric inhibitory polypeptide, in: J.H. Walsh, G.J. Dockray (Eds.), Gut Peptides: Biochemistry and Physiology, Raven Press, New York, 1994, pp. 217-259.
9. E. Penman, J.A.H. Wass, S. Medbank, L.M. Morgan, J. Lewis, G.M. Besser, L.H. Rees, Response of circulating somatostatin to nutritional stimuli in normal subjects, Gastroenterology 81 (1981) 692-699.
10. J.C. Brown, V. Mutt, R.A. Pedersen, Further purification of a polypeptide demonstrating enterogastrone activity, J. Physiol. 209 (1970) 57-64.
11. L.M. Morgan, P.R. Flatt, V. Marks, Nutrient regulation of the entero-insular axis and insulin secretion, Nutr. Res. Rev. 1 (1988) 79-97.
12. L. Morgan, Insulin secretion and the enteroinsular axis, in: P.R. Flatt (Ed.), Nutrient Regulation of Insulin Secretion, Portland Press, London, 1992, pp. 1-22.
13. M.B. Wheeler, R.W. Gelling, C.H.S. McIntosh, J. Georgioi, J. Brown, R.A. Pedersen, Functional expression of the rat pancreatic islet glucose-dependent insulinotropic polypeptide receptor: ligand binding and intracellular signalling properties, Endocrinology 136 (1995) 4629-4639.
14. D.K. Andersen, D. Elahi, J.C. Brown, J.D. Tobin, R. Andres, Oral glucose augmentation of insulin secretion. Interactions of gastric inhibitory polypeptide with ambient glucose and insulin levels, J. Clin. Invest. 62 (1978) 152-161.
15. B. Gallwitz, M. Witt, U.R. Folsch, W.E. Schmidt, Binding specificity and signal transduction of receptors for glucagon-like peptide-1(7-36)amide and gastric inhibitory polypeptide on RINm5F insulinoma cells, J. Mol. Endocrinol. 10 (1993) 259-268.
16. M. Maletti, B. Portha, M. Carlquist, M. Kergoat, M. Laburthe, J.C. Marie, G. Rosselin, Evidence for the characterization of specific high affinity binding sites for the gastric inhibitory polypeptide in pancreatic B-cells, Endocrinology 115 (1984) 1324-1331.
17. R.A. Pedersen, J.C. Brown, The insulinotropic action of gastric inhibitory polypeptide in the perfused isolated rat pancreas, Endocrinology 99 (1976) 780-785.
18. M. Maletti, J.J. Altman, B. Hui, P. Hoa, M. Carlquist, G. Rosselin, Evidence of functional gastric inhibitory polypeptide (GIP) receptors in human insulinoma. Binding of synthetic human GIP 1-31 and activation of adenylate cyclase, Diabetes 36 (1987) 1336-1340.
19. [1-3]OH, Digestion 46 (1990) 86.
20. N.H. McClenaghan, C.R. Barnett, E. Ah-Sing, Y.H.A. Abdel-Wahab, F.P.M. O'Harte, T.-W. Yoon, S.K. Swanston-Flatt, P.R. Flatt, Characterization of a novel glucose-responsive insulin-secreting cell line, BRIN-BD11, produced by electrofusion, Diabetes 45 (1996) 1132-1140.
21. F.P.M. O'Harte, A.M. Gray, P.R. Flatt, Gastric inhibitory polypeptide and effects of glycation on glucose transport and metabolism in isolated mouse abdominal muscle, J. Endocrinol. 156 (1998) 237-243.
22. F.P.M. O'Harte, C.S. Bockman, P.W. Abel, J.M. Conlon, Isolation, structural characterization and pharmacological activity of dog neuromedin U, Peptides 12 (1991) 11-15.
23. P.R. Flatt, C.J. Bailey, Abnormal plasma glucose and insulin responses in heterozygous lean (ob/+) mice, Diabetologia 20 (1981) 573-577.
24. T.J. Kieffer, V.C. Verchere, C.D. Fell, Z. Huang, J.C. Brown, R.A. Pedersen, Gastric inhibitory polypeptide (GIP)-stimulated insulin release from a tumor-derived beta-cell line (beta-TC3), Can. J. Physiol. Pharmacol. 71 (1993) 917-922.
25. K. Moens, H. Heimberg, D. Flamez, P. Huypens, E. Quartier, Z. Ling, D. Pipeleers, S. Gremlich, B. Thorens, F. Schuit, Expression and functional activity of glucagon, glucagon-like peptide 1, and glucose-dependent insulinotropic peptide receptors in rat pancreatic islet cells, Diabetes 45 (1996) 257-261.
26. A. Couvineau, B. Amirinoff, N. Vauclin-Jacques, M. Laburthe, The GIP receptor on pancreatic beta cell tumor: molecular identification by covalent cross-linking, Biochem. Biophys. Res. Commun. 122 (1984) 283-288.
27. T.B. Usdin, E. Mezey, D.C. Button, M.J. Brownstein, T.I. Bonner, Gastric inhibitory polypeptide receptor, a member of the secretin-vasoactive polypeptide receptor family, is widely distributed in peripheral organs and the brain, Endocrinology 133 (1993) 2861-2870.
28. J. Szecowka, V. Grill, E. Sandberg, S. Effendic, Effect of GIP on the secretion of insulin and somatostatin and the accumulation of cyclic AMP in vitro in the rat, Acta Endocrinol. 99 (1982) 416-421.
29. M. Lu, M.B. Wheeler, X.-H. Leng, A.E. Boyd, The role of the free cytosolic calcium level in β-cell signal transduction by gastric inhibitory polypeptide and glucagon-like peptide 1(7-37), Endocrinology 132 (1993) 94-100.
30. F.P.M. O'Harte, M.H. Mooney, C.M.N. Kelly, P.R. Flatt, Glycated cholecystokinin-8 has an enhanced satiating activity and is protected against enzymatic degradation, Diabetes 47 (1998) in press.
31. K. Arai, S. Iizuka, Y. Tada, K. Oikawa, N. Taniguchi, Increase in the glucosylated form of erythrocyte Cu-Zn-superoxide dismutase in diabetes and close association of the non-enzymatic glucosylation with the enzyme activity, Biochim. Biophys. Acta 924 (1987) 292-296.
32. Y.H.A. Abdel-Wahab, F.P.M. O'Harte, A.C. Boyd, C.R. Barnett, P.R. Flatt, Glycation of insulin results in reduced biological activity in mice, Acta Diabetol. 34 (1997) 265-270.
33. F.P.M. O'Harte, Y.H.A. Abdel-Wahab, J.M. Conlon, P.R. Flatt, Glycation of glucagon-like peptide-1(7-36)amide: Characterization and impaired action on rat insulin secreting cells, Diabetologia 41 (1998) in press.
34. W.S. Zawalich, N. Takuwa, V.A. Diaz, H. Rasmussen, Interactions of cholecystokinin and glucose in rat pancreatic islets, Diabetes 36 (1987) 426-433.
35. R. Komatsu, T. Matsuyama, M. Namba, N. Watanabe, H. Itoh, N. Kono, S. Tarui, Glucagonostatic and insulinotropic action of glucagon-like peptide-1(7-36)amide, Diabetes 38 (1989) 902-905.
36. J. Dupré, S.A. Ross, D. Watson, J.C. Brown, Stimulation of insulin secretion by gastric inhibitory polypeptide in man, J. Clin. Endocrinol. Metab. 37 (1973) 826-828.
37. D. Elahi, D.K. Andersen, J.C. Brown, Pancreatic α- and β-cell responses to GIP infusion in normal man, Am. J. Physiol. 37 (1979) E185-E191.
38. M. Kuzio, J.R. Dryburgh, K.M. Molloy, J.C. Brown, Radioimmunoassay for gastric inhibitory polypeptide, Gastroenterology 66 (1974) 357-364.
39. M. Maletti, M. Carlquist, B. Portha, M. Kergoat, V. Mutt, G. Rosselin, Structural requirements for gastric inhibitory polypeptide (GIP) receptor binding and stimulation of insulin release, Peptides 7 (1986) 75-78.
40. S. Suzuki, K. Kawai, S. Ohashi, Y. Watanabe, K. Yamashita, Comparison of the insulinotropic activity of the glucagon-superfamily peptides in rat pancreas perfusion, Horm. Metab. Res. 24 (1992) 458-461.
41. R. Mentlein, B. Gallwitz, W.E. Schmidt, Dipeptidyl-peptidase IV hydrolyses gastric inhibitory polypeptide, glucagon-like peptide-1(7-36)amide, peptide histidine methionine and is responsible for their degradation in human serum, Eur. J. Biochem. 214 (1993) 829-835.
42. R.P. Pauly, F. Rosche, M. Wermann, C.H.S. McIntosh, R.A. Pederson, H.-U. Demuth, Investigation of glucose-dependent insulinotropic polypeptide-(1-42) and glucagon-like peptide-1(7-36) degradation in vitro by dipeptidyl peptidase IV using matrix-assisted laser desorption, J. Biol. Chem. 271 (1996) 23222-23229.
43. A.J. Moody, K. Damm Jorgensen, L. Thim, Structure-function relationships in porcine GIP, Diabetologia 21, (abstract) (1981) 306.
44. 1-42 action in vitro, Regul. Pept. 69 (1997) 151-154.
45. L. Moroder, A. Hallet, P. Thamm, L. Wilschowitz, J.C. Brown, E. Wünsch, Studies on gastric inhibitory polypeptide: synthesis of the octatriacontapeptide GIP 1-38 with full insulinotropic activity, Scand. J. Gastroenterol. 13, (Suppl. 49) (1978) 129.
46. F.P.M. O'Harte, M. Mooney, P.R. Flatt, Glycated gastric inhibitory polypeptide exhibits aminopeptidase resistance and enhanced insulinotropic activity, Diabetologia 41 (Suppl. 1) (1998) A183.
47. R.A. Liddle, Cholecystokinin, in: J.H. Walsh, G.J. Dockray (Eds.), Gut Peptides: Biochemistry and Physiology, Raven Press, New York, 1994, pp. 175-216.
48. H.-C. Fehmann, R. Göke, B. Göke, Cell and molecular biology of the incretin hormones glucagon-like peptide-1 and glucose-dependent insulin releasing polypeptide, Endocr. Rev. 16 (1995) 390-410.
49. Y.H.A. Abdel-Wahab, F.P.M. O'Harte, H. Ratcliff, N.H. McClenaghan, C.R. Barnett, P.R. Flatt, Glycation of insulin in the islets of Langerhans of normal and diabetic animals, Diabetes 45 (1996) 1489-1496.
50. Y.H.A. Abdel-Wahab, F.P.M. O'Harte, C.R. Barnett, P.R. Flatt, Characterization of insulin glycation in insulin-secreting cells maintained in tissue culture, J. Endocrinol. 152 (1997) 59-67.